The Payoff Framework

    Not every intervention deserves your time.

    Beyond23 separates strong evidence from good marketing—then connects your labs, wearables and health history to show what could matter for you.

    Explore the read

    The evidence landscape

    10 interventions reviewed
    EMERGING EVIDENCEESTABLISHED EVIDENCE →HIGHER POTENTIAL PAYOFF ↑Zone 2ResistanceSleepCreatineSaunaGLP-1
    Do firstUse when matchedOptionalNot recommended yetbubble size ≈ cost

    Illustrative positions from published evidence — not any individual's ranking. Hover or tap a bubble.

    How the framework works

    First, clear the evidence bar. Then calculate the payoff.

    Interventions with inadequate evidence or unacceptable risk do not reach your list. Those that remain are ranked by expected benefit, personal relevance, effort and cost.

    01·Cost

    What it costs

    Upfront and ongoing, in real money. A free walk and a ₹15,000 infusion don't belong in the same conversation until you've weighed what each one returns.

    02·Effort

    What it asks of you

    The adherence burden most tools quietly ignore. A daily capsule and a weekly clinic visit are not the same ask — and the best plan is the one you'll actually keep.

    03·Return

    What you stand to gain

    Not a fixed label. It's the strength of the evidence, the size of the effect, and how far you personally sit from optimal on the markers it moves. That last part is why no generic chart can finish the job.

    The evidence bar

    Four things must be true before we recommend it.

    01

    Mechanism

    A plausible biological pathway to the outcome — not just a correlation in a headline.

    02

    Effect size

    A change large enough to notice against the noise of a real human life, not just statistical significance.

    03

    Replication

    The finding survives being tested by researchers who aren't rooting for it.

    04

    Safety margin

    The downside is understood, bounded, and worth what the upside offers on your specific numbers.

    One worked example

    How the framework reads a single intervention.

    Before scrolling the full library, here is one card fully unpacked — evidence, when it is most relevant, what to keep in perspective, and how we would track it.

    DO FIRSTEvidence: Strong for health outcomes

    Steady aerobic training

    Build aerobic fitness with repeatable, conversational-pace work. Consistency matters more than finding a perfect ‘Zone 2’.

    Cost
    Low
    Effort
    Medium
    Full brief

    What the evidence supports

    Regular moderate aerobic activity improves cardiorespiratory fitness and is associated with lower cardiovascular, metabolic and all-cause health risk.

    Most relevant when

    Your aerobic fitness or weekly movement is low, or most of your activity is brief and high-intensity.

    Keep in perspective

    ‘Zone 2’ is a practical way to regulate intensity, not a uniquely proven biological threshold. A pace you can sustain and repeat is more important than a perfect wearable calculation.

    Safety

    Build gradually. New chest pain, faintness or disproportionate breathlessness warrants medical review.

    The reading room

    How we read 10 popular interventions.

    Evidence strength, personal relevance, and safety are separate questions. A card can be strong on one and quiet on another.

    Evidence reviewed · July 2026·Reviewed by the Beyond23 medical team

    Start here · the full evidence spectrum

    DO FIRSTEvidence: Strong for health outcomes

    Steady aerobic training

    Build aerobic fitness with repeatable, conversational-pace work. Consistency matters more than finding a perfect ‘Zone 2’.

    Cost
    Low
    Effort
    Medium
    Full brief
    DO FIRSTEvidence: Strong

    Resistance training

    Build and preserve the strength, muscle and function that make a longer life more capable.

    Cost
    Low
    Effort
    Medium
    Full brief
    DO FIRSTEvidence: Moderate

    Sleep consistency

    A regular sleep-wake rhythm may matter nearly as much as how long you sleep.

    Cost
    Low
    Effort
    Medium
    Full brief
    USE WHEN MATCHEDEvidence: Strong in eligible patients

    GLP-1 medications

    A powerful clinical tool for appropriate metabolic risk — not a universal longevity drug.

    Cost
    High
    Effort
    Medium
    Full brief
    OPTIONALEvidence: Limited–moderate

    Sauna

    Enjoyable and potentially beneficial — but the strongest longevity claims remain observational.

    Cost
    Medium
    Effort
    Low
    Full brief

    The rest of the field

    USE WHEN MATCHEDEvidence: Strong for strength

    Creatine monohydrate

    One of the better-supported supplements for improving training-driven strength and lean mass.

    Cost
    Low
    Effort
    Low
    Full brief
    USE WHEN MATCHEDEvidence: Strong for triglycerides

    Omega-3 (EPA/DHA)

    Useful for specific lipid and dietary needs; not every formulation delivers the same benefit.

    Cost
    Medium
    Effort
    Low
    Full brief
    USE WHEN MATCHEDEvidence: Limited–moderate

    Berberine

    May modestly improve glucose and lipids, but evidence quality and product quality vary.

    Cost
    Low–Medium
    Effort
    Low
    Full brief
    OPTIONALEvidence: Limited

    Cold plunge

    May improve short-term recovery, but it is not proven to extend life — and timing matters.

    Cost
    Medium
    Effort
    Medium
    Full brief
    NOT RECOMMENDED YETEvidence: Insufficient

    NAD⁺ IV drips

    Expensive and invasive, with no convincing evidence of meaningful healthspan benefit.

    Cost
    High
    Effort
    High
    Full brief

    Your payoff

    See whether this belongs in your plan, what it could realistically change, and where it ranks against your other options.

    • Personal relevance
    • Signals it may improve
    • Priority versus your alternatives
    • Recommended starting point
    • How we would track response

    Requires your health history, labs and available wearable data.

    Educational information, not a diagnosis or prescription. Medication decisions require consultation with a qualified clinician.

    FAQ

    Questions people ask us.

    We weigh three lenses together — cost, effort, and return — against your actual markers. Something only reaches your do-first list when the evidence is real, the effect size is meaningful, and the gap it closes is one you personally have.

    You've seen how we think.
    Now see it think about you.

    Connect your labs and B23 ranks every one of these against your own markers — in order, with the reasoning behind each place.

    Take the BioAge — free
    Evidence-first, no trends
    Ranked against your markers
    4-point evidence bar